IP Intelligence Weekly
Week of Nov 15, 2026 - Nov 22, 2026 - Key patent trends and opportunities across AI/ML, Quantum, HealthTech, EnergyTech and DeepTech
This Week in Patent Intelligence
Mixed sentiment ran through all three daily reports this week, but beneath it, performance diverged sharply by sector. Deeptech opened the week strongly on Monday, with ASML up 9.5% over 30 days and semiconductor patents posting high innovation scores. By Thursday the picture had split. ONTO was down 21.7% over the same 30-day window, a reminder that a strong sector label does not protect every name in it. For IP investors, the lesson is to look at company-level patent quality and commercial exposure rather than the sector headline.
AI-ML led on Tuesday, with a 15.8% 30-day TRS gain. Healthtech took the lead on Thursday with a 14.3% gain, driven by ILMN. Energytech lagged or faced headwinds in each report, which suggests capital is rotating toward technology and life-science innovation and away from traditional energy. Geopolitical tension and policy shifts were flagged repeatedly as the main risks to that rotation, particularly for AI and energy.
A note on data: the top-patent list for AI-ML was empty in this week's feed, so we cannot cite specific patent IDs. We would rather leave them out than invent them. Readers should treat the sector-level read as directional until patent-level detail is available, and check underlying filings before acting on it.
Domain Spotlight: Ai Ml
Tokenization Watch
US11504071B2
Patient risk assessment based on data from multiple sources in a healthcare facility
Conservative
$572,773
Base
$954,622
Optimistic
$1,718,319
This patent shows strong tokenization readiness based on ownership verification status, market fit, and commercial potential indicators.
Trending in IP Markets
Patent activity and equity performance moved together at the sector level this week. Deeptech's high semiconductor innovation scores matched ASML's rally, and AI-ML and healthtech gains matched the sectors that investors favored. The ONTO decline shows that patent strength and share-price performance can diverge at the company level, especially when geopolitical and policy risks are in play.
Get the full daily analysis in your inbox
14-day free trial - no credit card required.
Start Free Trial